REG - CyanConnode Holdings - Director Option Grants

Cyanconnode HoldingsAnnouncement

17/11/2023 16:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231117:nRSQ8802Ta&default-theme=true

RNS Number : 8802T  CyanConnode Holdings PLC  17 November 2023

17 November 2023

CyanConnode Holdings plc

("CyanConnode" or the "Company")

Issue of Share Options

CyanConnode (AIM:CYAN.L), the world leader in narrowband radio mesh networks,
announces that, on 17 November 2023, it awarded options to acquire ordinary
shares of 2 pence per share in the Company ("Options") to John Cronin,
Executive Chairman and to Heather Peacock, Chief Financial Officer, as
follows:

 Director         No of options  Exercise price (p)  Vesting
 John Cronin      600,000        15.75               one third at grant and one third on each of 31 March 2024 and 31 March 2025
                  506,082        14.00               one third at grant and one third on each of 31 March 2024 and 31 March 2025
                  442,857        17.00               one third on each of 31 January 2024, 31 January 2025 and 31 January 2026
                  1,548,949

 Heather Peacock  600,000        15.75               one third at grant and one third on each of 31 March 2024 and 31 March 2025
                  506,082        14.00               one third at grant and one third on each of 31 March 2024 and 31 March 2025
                  442,857        17.00               one third on each of 31 January 2024, 31 January 2025 and 31 January 2026
                  682,642

These are the first share options awarded to the directors in over two years.
This brings the total options held by John Cronin to 3,256,420 being 1.09% of
issued share capital and options held by Heather Peacock to 2,191,850 being
0.73% of issued share capital. The above options have been awarded as part of
the Company's Unapproved Share Option Scheme. It is anticipated that the
options granted today will be converted into shares to be held in the
Company's Joint Share ownership Plan ("JSOP") as soon as appropriate, with the
same vesting prices and dates as set out above.

In addition to the above share options John Cronin and Heather Peacock
currently hold the following shares in the Company's JSOP.

                                             Participation Price              £                Shares in JSOP  % of share capital

 Director         Grant Date   Expiry Date
 John Cronin      10/11/21     10/11/26      0.145                                             5,672,359
                                                                                               5,672,359       1.90%
 Heather Peacock  10/11/21     10/11/26      0.145                                             1,331,498
                                                                                               1,331,498       0.45%

 

Enquiries:

 CyanConnode Holdings plc                                 www.cyanconnode.com (http://www.cyanconnode.com)
 John Cronin, Executive Chairman                          Tel: +44 (0) 1223 865 750

 Strand Hanson Limited (Nominated and Financial Adviser)
 James Harris / Richard Johnson / David Asquith           Tel: +44 (0) 20 7409 3494

                                                          Tel:+44 (0)20 3829 5000

 Zeus Capital Limited (Sole Bookrunner and Broker)

 Simon Johnson / Louisa Waddell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHNKOBQPBDDBDD